hotspot -WSS

hotspot

author：focus 2025-09-29 21:28:44 - browse：3551

Wire medical stent -- coverage from STAT — Adobe

PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical treatments and, eventually, what procedures patients undergo.

It starts with coronary angioplasty, one of the most common procedures in medicine, performed hundreds of thousands of times a year in the U.S. alone. A balloon catheter is snaked up into a clogged artery in the heart and expanded to open the blood vessel. It leaves behind a metal scaffold, called a stent, that is used to prop the artery open.

In people who have just had a heart attack, this can be lifesaving. But frequently angioplasty is used mainly to relieve chest pain, or angina. And though this use dates back decades, angioplasty and stents have never passed the basic test any new pill for relieving symptoms has to clear: outperforming a placebo in a clinical trial where patients were blinded, meaning they don’t know whether they got the treatment or not.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Female surgeons have lower rates of long

focus

WSS

What to expect at HLTH 2023, the health care industry conference

Readout LOUD podcast: Merger Mondays, Ozempic panic

Better Therapeutics data on benefit with GLP

STAT Readout: Today's biotech news includes Sana and Amylyx

A revolution in caring for preterm infants

FDA rejects Alnylam's heart disease treatment over insufficient data

leisure time

hotspot

explore

Sports medicine is finally prioritizing gender equality

Liquid biopsy for lung cancer is launched by Delfi

Virginia high school admissions case could be legal follow

Sana to lay off nearly a third of staff, de

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Humana CEO Bruce Broussard to step down in 2024

Dobbs anniversary: the lost opportunity of abortion as health care

FDA panel signals lack of confidence in Amgen cancer drug data

In Memoriam: Notable people who died in 2023

VC firm General Catalyst wants to buy a health system

focus

Readout LOUD podcast: Merger Mondays, Ozempic panic

How doctors and nurses shape Google's AI

VC firm General Catalyst wants to buy a health system

A virus, fished out of a lake, may have saved a man’s life

European regulators recommend Amylyx's ALS drug be rejected

Physician executives need more than on

leisure time

focus

knowledge

knowledge